Pharmaceuticals & Life Sciences
Custom Model Fine-tuning for Pharmaceuticals & Life Sciences
Custom Model Fine-tuning for pharmaceuticals & life sciences, built around the constraint that defines the sector: GxP validation means every system change needs documented evidence before it reaches production.
- Regulations in scope
- 5
- Systems we integrate
- 5
- Typical first release
- 6 weeks
What changes when it is pharmaceuticals & life sciences
Training data quality dominates everything else. A thousand carefully curated examples routinely beat fifty thousand scraped ones, and the curation is the real work.
In pharmaceuticals & life sciences, GxP validation means every system change needs documented evidence before it reaches production. That single fact reshapes how custom model fine-tuning has to be built here, the guardrails, the approval points and the evidence trail are design inputs rather than things bolted on before go-live.
The workload we are most often asked to take on first is regulatory dossier assembly, usually integrated against QMS. Integration comes before intelligence. A model that cannot reach your systems of record is a demo with good manners.
Deployed across regulated and unregulated sectors, with audit trails where the regulator expects them. You own the code, the models where they are open-weight, and the documentation to run it without us.
The sector constraints we design around
- Defining constraint
- GxP validation means every system change needs documented evidence before it reaches production
- Regulations in scope
- CDSCO · US FDA 21 CFR Part 11 · EU GMP Annex 11 · GxP validation · ICH guidelines
- Systems of record
- LIMS · QMS · eTMF · SAP · pharmacovigilance databases
- Where we usually start
- batch record review
Custom Model Fine-tuning workloads in pharmaceuticals & life sciences
- batch record review
- adverse event intake and coding
- regulatory dossier assembly
- deviation and CAPA drafting
- literature monitoring
What is included
- Honest assessment of whether fine-tuning is warranted
- Training data curation and quality review
- LoRA or full fine-tune as the workload justifies
- Evaluation against the prompted baseline
- Inference deployment and cost comparison
- Retraining pipeline as your data grows
Questions from this sector
Can an AI system be GxP validated?
Yes, with a documented validation approach, IQ/OQ/PQ, defined intended use, change control and evidence of consistent performance. We build the validation pack alongside the system, not afterwards.
How do you handle 21 CFR Part 11?
Audit trails, electronic signatures, access control and record integrity designed in from the start, because retrofitting them is effectively a rebuild.
Should we fine-tune?
Usually not first. Prompting and retrieval solve most problems more cheaply. Fine-tuning wins for consistent format, narrow domain style, and high-volume tasks where a smaller model can replace a larger one.
How much data do we need?
For LoRA on a narrow task, often a few thousand high-quality examples. Quality matters far more than volume. We review the dataset before training anything.
Can we own the model?
With open-weight base models, yes. You hold the weights and can run them on your own infrastructure indefinitely.
Other capabilities for pharmaceuticals & life sciences
- AI Agent Development for Pharmaceuticals & Life Sciences
- Agentic Workflow Automation for Pharmaceuticals & Life Sciences
- LLM Application Development for Pharmaceuticals & Life Sciences
- RAG & Knowledge Retrieval for Pharmaceuticals & Life Sciences
- Chatbot Development for Pharmaceuticals & Life Sciences
- Document Processing & IDP for Pharmaceuticals & Life Sciences
- AI Copilot Development for Pharmaceuticals & Life Sciences
- Data Engineering for Pharmaceuticals & Life Sciences
- Enterprise AI Platform for Pharmaceuticals & Life Sciences
- Workflow & Integration Automation for Pharmaceuticals & Life Sciences
Custom Model Fine-tuning for pharmaceuticals & life sciences, worth a conversation?
Tell us the workload and the regulation it sits under. We will tell you what is realistic.
Or email bd@dtrasglobal.com · call +91 74118 77878
